CYP7A1, also known as cytochrome P450 7A1, is a key enzyme in the human body and plays an important role in cholesterol metabolism. It is primarily responsible for converting cholesterol into bile acids, a critical step in maintaining cholesterol balance in the body. CYP7A1 is particularly important in the liver, where most cholesterol metabolism occurs. Its activity can be affected by a range of factors, from dietary cholesterol intake to various hormones and medications. Mutations in the CYP7A1 gene can cause certain inherited diseases, most notably cerebrotendinous xanthomatosis, a disease characterized by the accumulation of cholesterol in abnormal areas, causing a variety of symptoms. Due to its importance in cholesterol regulation, this enzyme is also a potential target for drugs aimed at lowering cholesterol levels.
HeLa cells are a commonly used lab resource, derived from an immortal line of human cervical cancer cells originally taken from Henrietta Lacks in 1951. They are known for their robustness and adaptability, which can add an extra degree of reliability to studies using the Human CYP7A1 Stable Cell Line. Human CYP7A1 Stable Cell Line - HeLa is a cell line engineered to stably express CYP7A1. The stability of CYP7A1 expression in these cells makes them a reliable and consistent model for studying a variety of topics related to cholesterol metabolism and bile acid synthesis.
The initiating and rate-limiting step of the classical pathway for bile acid biosynthesis is the 7α-hydroxylation of cholesterol, a reaction catalyzed by cholesterol 7α-hydroxylase (CYP7A1). The specific aim of this study was to determine the effects of CYP7A1 overexpression on key regulatory steps of cholesterol homeostasis in hepatocytes using primary human hepatocytes (PHH) and HepG2 cells.
Here, the researchers determined the effects of CYP7A1 overexpression on several parameters of bile acid and hepatic cholesterol metabolism in primary human hepatocytes (PHH) and HepG2 cells. The data showed that overexpression of CYP7A1 in cultured cells from humans resulted in a significant increase in bile acid synthesis via the "classical" pathway. The cholesterol homeostasis response in HepG2 cells included downregulation of HMGR and upregulation of LDLR. This response suggests that overexpression of CYP7A1 in humans could be an effective approach to lower serum cholesterol.
Figure 1. Effect of overexpression of CYP7A1 on bile acid synthesis in HepG2 cell cultures. An approximately twofold increase in total bile acids synthesized by HepG2 cells was observed in the culture medium after CYP7A1 overexpression. (Pandak W M, et al., 2001)
In drug development, the human CYP7A1 stable cell line - HeLa provides an excellent tool to evaluate the impact of potential drug candidates on CYP7A1 activity. Such toxicity testing is critical in the early stages of drug discovery to predict how drugs affect metabolic pathways and prevent harmful side effects in clinical trials.
In studies related to cholesterol metabolism and inherited metabolic disorders, these cells can be used to study the biological function of the CYP7A1 enzyme and develop targeted therapeutic strategies. It can also be used to study the precise role of CYP7A1 in the onset and progression of cardiovascular disease, diabetes, and certain types of cancer, all of which are associated with alterations in cholesterol homeostasis.
In biochemistry, the human CYP7A1 stable cell line - HeLa can be used to elucidate the molecular details of enzyme-substrate interactions within the cholesterol pathway, providing insights into the regulatory mechanisms controlling cholesterol metabolism.
Customer Reviews
Reproducibility
I've been using the Human CYP7A1 Stable Cell Line - HeLa for over six months in my research on cholesterol metabolism, and the reproducibility of my results has been outstanding. The consistency across different batches has significantly enhanced the reliability of my experimental data.
Time Efficiency in Experiments
This cell line has drastically reduced the time I spend on my experiments. The stable expression of CYP7A1 means I no longer need to transfect the cells repeatedly, which has streamlined my workflow.
Valuable tool
The versatility of the Human CYP7A1 Stable Cell Line - HeLa is impressive. We've used it in a variety of assays, including enzyme activity assays, qPCR, and Western blotting, all with exceptional results.
Write a Review